16h
AbbVie Scores Canadian Reimbursement Recommendations For Blockbuster Ulcerative Colitis Drug Skyrizi
AbbVie secures Canadian support for Skyrizi in ulcerative colitis with new reimbursement recommendations and a completed pCPA agreement.
SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug ...
SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug ...
From heart health to neurological decline, the retina's tiny vessels and nerves can reveal silent disease changes long before patients notice anything is wrong ...
A new study found that a popular low-calorie sweetener commonly used in sugar-free gum, candies and diet-friendly baked goods ...
Gut bacteria shown to produce serotonin, revealing new pathways for IBS therapy. Researchers at the University of Gothenburg in Sweden have uncovered new details about how gut bacteria interact with ...
Walk into a typical supermarket in the United States, and much of what you see — breakfast cereals, frozen meals, processed ...
Thanksgiving is over, but the holiday hazards for pets are just getting started. Every year, veterinary clinics see a spike ...
When British expatriate Melanie discovered that she developed an intolerance to gluten; she remembers feeling “overwhelmed, ...
Prostate cancer decision by UK National Screening Committee is expected to reject offering PSA test to Black men and those ...
The company has recalled its Locatelli Grated Pecorino Romano Cheese with Wegmans’ scale labels due to potential Listeria ...
There is currently no screening programme for prostate cancer, the most common cancer in men. But there has been some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback